Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-20-049421

Chief Executive Officer gave up 779 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Kulkarni Samarth · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-09-02 Shares withheld for taxes : show line 1 in the form −779 $94.15 $73,343 169,968 D
Loading xslF345X03/doc4.xml…